Full Text View
Tabular View
No Study Results Posted
Related Studies
To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.
This study has been completed.
Study NCT00141336   Information provided by Pfizer

First Received on August 30, 2005.   Last Updated on December 28, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Seizure Disorder, Partial
Additional conditions recognized in this trial
Epilepsies, Partial
Epilepsy
Seizures
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Neurologic Manifestations
Signs and Symptoms
Interventions listed in this trial
Pregabalin
More general drug interventions related to this trial
Analgesics
Anticonvulsants
Central Nervous System Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services